BIOMAT Database Logo BIOMAT Database Logo

Clomipramine-induced agranulocytosis and its treatment with G-CSF. 1993

K A Hunt, and M P Resnick

UI MeSH Term Description Entries
D002997 Clomipramine A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine. Chlorimipramine,Anafranil,Chlomipramine,Clomipramine Hydrochloride,Clomipramine Maleate (1:1),Clomipramine Monohydrochloride,Hydiphen,Hydrochloride, Clomipramine,Monohydrochloride, Clomipramine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid

Related Publications

K A Hunt, and M P Resnick
Hyperleucocytosis following G-CSF treatment for sulfasalazine-induced agranulocytosis.
July 2015, BMJ case reports,
K A Hunt, and M P Resnick
Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSF.
January 2001, Hematology (Amsterdam, Netherlands),
K A Hunt, and M P Resnick
Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
January 1996, Archivum immunologiae et therapiae experimentalis,
K A Hunt, and M P Resnick
[Treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor G-CSF].
March 1994, Psychiatrische Praxis,
K A Hunt, and M P Resnick
Clozapine-induced agranulocytosis and use of g-csf.
January 1998, Indian journal of psychiatry,
K A Hunt, and M P Resnick
Rheumatoid arthritis exacerbation by G-CSF treatment for bucillamine-induced agranulocytosis.
January 1995, Clinical and experimental rheumatology,
K A Hunt, and M P Resnick
[Treatment of drug induced agranulocytosis with granulocyte-macrophage colony stimulating factor (G-CSF)].
February 1994, Polskie Archiwum Medycyny Wewnetrznej,
K A Hunt, and M P Resnick
Successful treatment of clozapine induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF).
April 1992, British journal of haematology,
K A Hunt, and M P Resnick
[Indications of G-CSF in patients with drug-induced agranulocytosis].
September 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K A Hunt, and M P Resnick
G-CSF and the management of clozapine-induced agranulocytosis.
September 1994, The Journal of clinical psychiatry,
Copied contents to your clipboard!